Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 597

1.

Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion.

Chen J, Sun Y, Ou Z, Yeh S, Huang CP, You B, Tsai YC, Sheu TJ, Zu X, Chang C.

EMBO Rep. 2020 Feb 13:e48467. doi: 10.15252/embr.201948467. [Epub ahead of print]

PMID:
32052578
2.

GT1b functions as a novel endogenous agonist of toll-like receptor 2 inducing neuropathic pain.

Lim H, Lee J, You B, Oh JH, Mok HJ, Kim YS, Yoon BE, Kim BG, Back SK, Park JS, Kim KP, Schnaar RL, Lee SJ.

EMBO J. 2020 Feb 6:e102214. doi: 10.15252/embj.2019102214. [Epub ahead of print]

PMID:
32030804
3.

Overexpression of ERBB3 promotes proliferation, migration, and angiogenesis in nasopharyngeal carcinoma.

Duan B, Zhu Z, You B, Shi S, Shan Y, Jiang P, Zhang Q, Bao L, Yin Y, You Y.

Int J Clin Exp Pathol. 2019 Aug 1;12(8):2931-2940. eCollection 2019.

4.

Conjunction of triboelectric nanogenerator with induction coils as wireless power sources and self-powered wireless sensors.

Zhang C, Chen J, Xuan W, Huang S, You B, Li W, Sun L, Jin H, Wang X, Dong S, Luo J, Flewitt AJ, Wang ZL.

Nat Commun. 2020 Jan 2;11(1):58. doi: 10.1038/s41467-019-13653-w.

5.

The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients.

You B, Mercier F, Assenat E, Langlois-Jacques C, Glehen O, Soulé J, Payen L, Kepenekian V, Dupuy M, Belouin F, Morency E, Saywell V, Flacelière M, Elies P, Liaud P, Mazard T, Maucort-Boulch D, Tan W, Vire B, Villeneuve L, Ychou M, Kohli M, Joubert D, Prieur A.

EBioMedicine. 2020 Jan;51:102574. doi: 10.1016/j.ebiom.2019.11.035. Epub 2019 Dec 24.

6.

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.

Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators.

N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361.

PMID:
31851799
7.

Androgen receptor reverses the oncometabolite R-2-hydroxyglutarate-induced prostate cancer cell invasion via suppressing the circRNA-51217/miRNA-646/TGFβ1/p-Smad2/3 signaling.

Xu H, Sun Y, You B, Huang CP, Ye D, Chang C.

Cancer Lett. 2020 Mar 1;472:151-164. doi: 10.1016/j.canlet.2019.12.014. Epub 2019 Dec 14.

8.

Are Older Patients with Cervical Cancer Managed Differently to Younger Patients? An International Survey.

Frelaut M, De Glas N, Zapardiel I, Kaidar-Person O, Kfoury M, You B, Banerjee S, Brain E, Falandry C, Rodrigues M.

Cancers (Basel). 2019 Dec 6;11(12). pii: E1955. doi: 10.3390/cancers11121955.

9.

Biodegradable Bi2 O2 Se Quantum Dots for Photoacoustic Imaging-Guided Cancer Photothermal Therapy.

Xie H, Liu M, You B, Luo G, Chen Y, Liu B, Jiang Z, Chu PK, Shao J, Yu XF.

Small. 2020 Jan;16(1):e1905208. doi: 10.1002/smll.201905208. Epub 2019 Dec 5.

PMID:
31805221
10.

Anti-insulin resistance effects of salidroside through mitochondrial quality control.

You B, Dun Y, Zhang W, Jiang L, Li H, Xie M, Liu Y, Liu S.

J Endocrinol. 2019 Dec 1. pii: JOE-19-0393.R2. doi: 10.1530/JOE-19-0393. [Epub ahead of print]

PMID:
31794423
11.

Developments in the construction of cyclopropanols.

Liu Q, You B, Xie G, Wang X.

Org Biomol Chem. 2020 Jan 2;18(2):191-204. doi: 10.1039/c9ob02197c. Review.

PMID:
31793614
12.

Effect of treatment period with LC478, a disubstituted adamantayl derivative, on P-glycoprotein inhibition: its application to increase docetaxel absorption in rats.

Han SY, Kim ES, You BH, Chae HS, Lu Q, Chin YW, Ahn HC, Chung SJ, Lee K, Choi YH.

Xenobiotica. 2019 Dec 6:1-12. doi: 10.1080/00498254.2019.1700318. [Epub ahead of print]

PMID:
31791185
13.

Exosomal miR-17-5p promotes angiogenesis in nasopharyngeal carcinoma via targeting BAMBI.

Duan B, Shi S, Yue H, You B, Shan Y, Zhu Z, Bao L, You Y.

J Cancer. 2019 Oct 22;10(26):6681-6692. doi: 10.7150/jca.30757. eCollection 2019.

14.

Stimuli-responsive nanoparticles for the codelivery of chemotherapeutic agents doxorubicin and siPD-L1 to enhance the antitumor effect.

Zhou YJ, Wan WJ, Tong Y, Chen MT, Wang DD, Wang Y, You BG, Liu Y, Zhang XN.

J Biomed Mater Res B Appl Biomater. 2019 Nov 20. doi: 10.1002/jbm.b.34516. [Epub ahead of print]

PMID:
31746127
15.

Agonist-induced 4-1BB activation prevents the development of Sjӧgren's syndrome-like sialadenitis in non-obese diabetic mice.

Zhou J, You BR, Yu Q.

Biochim Biophys Acta Mol Basis Dis. 2020 Mar 1;1866(3):165605. doi: 10.1016/j.bbadis.2019.165605. Epub 2019 Nov 15.

PMID:
31740402
16.

Characterization and genome sequencing of a novel T7-like lytic phage, kpssk3, infecting carbapenem-resistant Klebsiella pneumoniae.

Shi Y, Chen Y, Yang Z, Zhang Y, You B, Liu X, Chen P, Liu M, Zhang C, Luo X, Chen Y, Yuan Z, Chen J, Gong Y, Peng Y.

Arch Virol. 2020 Jan;165(1):97-104. doi: 10.1007/s00705-019-04447-y. Epub 2019 Nov 16.

PMID:
31734749
17.

HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2.

You BH, Yoon JH, Kang H, Lee EK, Lee SK, Nam JW.

Proc Natl Acad Sci U S A. 2019 Dec 3;116(49):24620-24629. doi: 10.1073/pnas.1912126116. Epub 2019 Nov 15.

18.

Near infrared light responsive self-healing superhydrophobic coating based on solid wastes.

Li W, Zhang X, Yu X, Wu G, Lei Y, Sun G, You B.

J Colloid Interface Sci. 2020 Feb 15;560:198-207. doi: 10.1016/j.jcis.2019.10.072. Epub 2019 Oct 19.

PMID:
31670017
19.

Type-A aortic dissection manifesting as acute inferior myocardial infarction: 2 case reports.

Wang W, Wu J, Zhao X, You B, Li C.

Medicine (Baltimore). 2019 Oct;98(43):e17662. doi: 10.1097/MD.0000000000017662.

20.

Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect via Multi-functional Nanoparticles for Orthotopic Non-Small Cell Lung Cancer Treatment.

Li F, Wang Y, Chen WL, Wang DD, Zhou YJ, You BG, Liu Y, Qu CX, Yang SD, Chen MT, Zhang XN.

Theranostics. 2019 Aug 12;9(20):5886-5898. doi: 10.7150/thno.32416. eCollection 2019.

21.

Application of artificial intelligence in the diagnosis of multiple primary lung cancer.

Li X, Hu B, Li H, You B.

Thorac Cancer. 2019 Nov;10(11):2168-2174. doi: 10.1111/1759-7714.13185. Epub 2019 Sep 17.

22.

Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapies.

Corbaux P, El-Madani M, Tod M, Péron J, Maillet D, Lopez J, Freyer G, You B.

Eur J Cancer. 2019 Oct;120:40-46. doi: 10.1016/j.ejca.2019.08.002. Epub 2019 Aug 31. Review.

PMID:
31479946
23.
24.

Clinical implications of clonal chromosomal abnormalities in Philadelphia negative cells in CML patients after treated with tyrosine kinase inhibitors.

Ni H, Sun X, Xu Y, Lyle D, Petersen P, Zhao X, Drum H, You B, Liu D, Liu C, Jiang JG.

Cancer Genet. 2019 Oct;238:44-49. doi: 10.1016/j.cancergen.2019.07.008. Epub 2019 Jul 24.

PMID:
31425925
25.

Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme.

Varnier R, Le Saux O, Chabaud S, Garin G, Sohier E, Wang Q, Paindavoine S, Pérol D, Baudet C, Attignon V, Pissaloux D, Heudel P, You B, Leyronnas C, Collard O, Trédan O, Bonnin N, Long J, Jacquin JP, Cassier PA, Derbel O, Freyer G, Viari A, Blay JY, Ray-Coquard I.

Eur J Cancer. 2019 Sep;118:156-165. doi: 10.1016/j.ejca.2019.06.017. Epub 2019 Jul 24.

PMID:
31351267
26.

Determination of Cetuximab in Plasma by Liquid Chromatography-High-Resolution Mass Spectrometry Orbitrap With a Stable Labeled 13C,15N-Cetuximab Internal Standard.

Millet A, Lebert D, Picard G, You B, Ceruse P, Guitton J.

Ther Drug Monit. 2019 Aug;41(4):467-475. doi: 10.1097/FTD.0000000000000613.

PMID:
31306393
28.

The Role of CDR1as in Proliferation and Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells.

Yang L, Bin Z, Hui S, Rong L, You B, Wu P, Han X, Qian H, Xu W.

Stem Cells Int. 2019 Jun 12;2019:2316834. doi: 10.1155/2019/2316834. eCollection 2019.

29.

Anti-inflammatory effect of aged black garlic on 12-O-tetradecanoylphorbol-13-acetate-induced dermatitis in mice.

You BR, Yoo JM, Baek SY, Kim MR.

Nutr Res Pract. 2019 Jun;13(3):189-195. doi: 10.4162/nrp.2019.13.3.189. Epub 2019 Mar 29.

30.

Doxorubicin and siRNA-PD-L1 co-delivery with T7 modified ROS-sensitive nanoparticles for tumor chemoimmunotherapy.

Wan WJ, Qu CX, Zhou YJ, Zhang L, Chen MT, Liu Y, You BG, Li F, Wang DD, Zhang XN.

Int J Pharm. 2019 Jul 20;566:731-744. doi: 10.1016/j.ijpharm.2019.06.030. Epub 2019 Jun 15.

PMID:
31212055
31.

Negative Charging of Transition-Metal Phosphides via Strong Electronic Coupling for Destabilization of Alkaline Water.

You B, Zhang Y, Jiao Y, Davey K, Qiao SZ.

Angew Chem Int Ed Engl. 2019 Aug 19;58(34):11796-11800. doi: 10.1002/anie.201906683. Epub 2019 Jul 12.

PMID:
31194286
32.

Inkjet-printed unclonable quantum dot fluorescent anti-counterfeiting labels with artificial intelligence authentication.

Liu Y, Han F, Li F, Zhao Y, Chen M, Xu Z, Zheng X, Hu H, Yao J, Guo T, Lin W, Zheng Y, You B, Liu P, Li Y, Qian L.

Nat Commun. 2019 Jun 3;10(1):2409. doi: 10.1038/s41467-019-10406-7.

33.

Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma.

Zhao E, Li L, Zhang W, Wang W, Chan Y, You B, Li X.

J Transl Med. 2019 May 27;17(1):177. doi: 10.1186/s12967-019-1927-y.

34.

[Effects of vitamin D3 on intestinal mucosal barrier of mice with severe burns].

Liu XZ, You B, Zhang YL, Yang ZC, Chen P, Shi YL, Chen Y, Chen YJ, Chen J, Peng YZ.

Zhonghua Shao Shang Za Zhi. 2019 Apr 20;35(4):284-291. doi: 10.3760/cma.j.issn.1009-2587.2019.04.008. Chinese.

PMID:
31060176
35.

Preparation and Characterization of Gas-Forming Polyacrylonitrile/Polymethylmethacrylate/Methylcyclohexane Nanocapsules for the Desorption of Optical Adhesive Films.

Son I, Lee B, Cho CH, Moon GT, Hwang J, Jang E, You B, Lee JH.

J Nanosci Nanotechnol. 2019 Oct 1;19(10):6256-6263. doi: 10.1166/jnn.2019.17034.

PMID:
31026945
36.

Global Transcriptomic Analysis of the Interactions between Phage φAbp1 and Extensively Drug-Resistant Acinetobacter baumannii.

Yang Z, Yin S, Li G, Wang J, Huang G, Jiang B, You B, Gong Y, Zhang C, Luo X, Peng Y, Zhao X.

mSystems. 2019 Apr 16;4(2). pii: e00068-19. doi: 10.1128/mSystems.00068-19. eCollection 2019 Mar-Apr.

37.

Mind the gap: observation windows to define periods of event ascertainment as a quality control method for longitudinal electronic health record data.

Althoff KN, Wong C, Hogan B, Desir F, You B, Humes E, Zhang J, Jing Y, Modur S, Lee JS, Freeman A, Kitahata M, Van Rompaey S, Mathews WC, Horberg MA, Silverberg MJ, Mayor AM, Salters K, Moore RD, Gange SJ; North American AIDS Cohort Collaboration on Research and Design.

Ann Epidemiol. 2019 May;33:54-63. doi: 10.1016/j.annepidem.2019.01.015. Epub 2019 Mar 4.

PMID:
31005552
38.

Lonicera japonica extract increases metformin distribution in the liver without change of systemic exposed metformin in rats.

Han SY, Chae HS, You BH, Chin YW, Kim H, Choi HS, Choi YH.

J Ethnopharmacol. 2019 Jun 28;238:111892. doi: 10.1016/j.jep.2019.111892. Epub 2019 Apr 17.

PMID:
31004727
39.

HOXB7 promotes proliferation and metastasis of glioma by regulating the Wnt/β-catenin pathway.

Huo XY, Zhang XY, Yuan F, Zhao XY, You BA.

Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2476-2485. doi: 10.26355/eurrev_201903_17395.

40.

Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study.

Colomban O, Tod M, Leary A, Ray-Coquard I, Lortholary A, Hardy-Bessard AC, Pfisterer J, Du Bois A, Kurzeder C, Burges A, Péron J, Freyer G, You B.

Clin Cancer Res. 2019 Sep 1;25(17):5342-5350. doi: 10.1158/1078-0432.CCR-18-3335. Epub 2019 Apr 1.

PMID:
30936122
41.

Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology.

Lavoue V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, Bendifallah S, Bolze PA, Bonnet F, Bourgin C, Chabbert-Buffet N, Collinet P, Courbiere B, De la Motte Rouge T, Devouassoux-Shisheboran M, Falandry C, Ferron G, Fournier L, Gladieff L, Golfier F, Gouy S, Guyon F, Lambaudie E, Leary A, Lecuru F, Lefrere-Belda MA, Leblanc E, Lemoine A, Narducci F, Ouldamer L, Pautier P, Planchamp F, Pouget N, Ray-Coquard I, Rousset-Jablonski C, Senechal-Davin C, Touboul C, Thomassin-Naggara I, Uzan C, You B, Daraï E.

J Gynecol Obstet Hum Reprod. 2019 Jun;48(6):369-378. doi: 10.1016/j.jogoh.2019.03.017. Epub 2019 Mar 30.

42.

Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up).

Lavoue V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, Bendifallah S, Bolze PA, Bonnet F, Bourgin C, Chabbert-Buffet N, Collinet P, Courbiere B, De la Motte Rouge T, Devouassoux-Shisheboran M, Falandry C, Ferron G, Fournier L, Gladieff L, Golfier F, Gouy S, Guyon F, Lambaudie E, Leary A, Lecuru F, Lefrere-Belda MA, Leblanc E, Lemoine A, Narducci F, Ouldamer L, Pautier P, Planchamp F, Pouget N, Ray-Coquard I, Rousset-Jablonski C, Senechal-Davin C, Touboul C, Thomassin-Naggara I, Uzan C, You B, Daraï E.

J Gynecol Obstet Hum Reprod. 2019 Jun;48(6):379-386. doi: 10.1016/j.jogoh.2019.03.018. Epub 2019 Mar 29.

43.

Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.

Lavoue V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, Bendifallah S, Bolze PA, Bonnet F, Bourgin C, Chabbert-Buffet N, Collinet P, Courbiere B, De la Motte Rouge T, Devouassoux-Shisheboran M, Falandry C, Ferron G, Fournier L, Gladieff L, Golfier F, Gouy S, Guyon F, Lambaudie E, Leary A, Lecuru F, Lefrere-Belda MA, Leblanc E, Lemoine A, Narducci F, Ouldamer L, Pautier P, Planchamp F, Pouget N, Ray-Coquard I, Rousset-Jablonski C, Senechal-Davin C, Touboul C, Thomassin-Naggara I, Uzan C, You B, Daraï E.

Eur J Obstet Gynecol Reprod Biol. 2019 May;236:214-223. doi: 10.1016/j.ejogrb.2019.03.010. Epub 2019 Mar 15.

44.

Characterization and genome annotation of a newly detected bacteriophage infecting multidrug-resistant Acinetobacter baumannii.

Yang Z, Liu X, Shi Y, Yin S, Shen W, Chen J, Chen Y, Chen Y, You B, Gong Y, Luo X, Zhang C, Yuan Z, Peng Y.

Arch Virol. 2019 Jun;164(6):1527-1533. doi: 10.1007/s00705-019-04213-0. Epub 2019 Mar 21.

45.

Pharmacokinetic Study of Osimertinib in Cancer Patients with Mild or Moderate Hepatic Impairment.

Grande E, Harvey RD, You B, Batlle JF, Galbraith H, Sarantopoulos J, Ramalingam SS, Mann H, So K, Johnson M, Vishwanathan K.

J Pharmacol Exp Ther. 2019 May;369(2):291-299. doi: 10.1124/jpet.118.255919. Epub 2019 Mar 14.

PMID:
30872388
46.

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.

Trédan O, Wang Q, Pissaloux D, Cassier P, de la Fouchardière A, Fayette J, Desseigne F, Ray-Coquard I, de la Fouchardière C, Frappaz D, Heudel PE, Bonneville-Levard A, Fléchon A, Sarabi M, Guibert P, Bachelot T, Pérol M, You B, Bonnin N, Collard O, Leyronnas C, Attignon V, Baudet C, Sohier E, Villemin JP, Viari A, Boyault S, Lantuejoul S, Paindavoine S, Treillleux I, Rodriguez C, Agrapart V, Corset V, Garin G, Chabaud S, Pérol D, Blay JY; ProfiLER investigators.

Ann Oncol. 2019 May 1;30(5):757-765. doi: 10.1093/annonc/mdz080.

PMID:
30865223
47.

Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma.

Mao Y, Yu Z, You B, Fang W, Badgwell B, Berry MF, Ceppa DP, Chen C, Chen H, Cuesta MA, D'Journo XB, Eslick GD, Fu J, Fu X, Gao S, He J, He J, Huang Y, Jiang G, Jiang Z, Kim JY, Li D, Li H, Li S, Liu D, Liu L, Liu Y, Li X, Li Y, Mao W, Molena D, Morse CR, Novoa NM, Tan L, Tan Q, Toker A, Tong T, Wang Q, Weksler B, Xu L, Xu S, Yan T, Zhang L, Zhang X, Zhang X, Zhang Z, Zhi X, Zhou Q.

J Thorac Dis. 2019 Jan;11(1):319-328. doi: 10.21037/jtd.2018.12.07. Review. No abstract available.

48.

[Management of epithelial ovarian cancer. Short text drafted from the French joint recommendations of FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa].

Lavoue V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, Bendifallah S, Bolze PA, Bonnet F, Bourgin C, Chabbert-Buffet N, Collinet P, Courbiere B, De la Motte Rouge T, Devouassoux-Shisheboran M, Falandry C, Ferron G, Fournier L, Gladieff L, Golfier F, Gouy S, Guyon F, Lambaudie E, Leary A, Lecuru F, Lefrere-Belda MA, Leblanc E, Lemoine A, Narducci F, Ouldamer L, Pautier P, Planchamp F, Pouget N, Ray-Coquard I, Rousset-Jablonski C, Senechal-Davin C, Touboul C, Thomassin-Naggara I, Uzan C, You B, Daraï E.

Bull Cancer. 2019 Apr;106(4):354-370. doi: 10.1016/j.bulcan.2019.01.014. Epub 2019 Mar 6. Review. French.

PMID:
30850152
49.

Fenofibrate induces human hepatoma Hep3B cells apoptosis and necroptosis through inhibition of thioesterase domain of fatty acid synthase.

You BJ, Hour MJ, Chen LY, Luo SC, Hsu PH, Lee HZ.

Sci Rep. 2019 Mar 1;9(1):3306. doi: 10.1038/s41598-019-39778-y.

50.

Enhancing Electrocatalytic Water Splitting by Strain Engineering.

You B, Tang MT, Tsai C, Abild-Pedersen F, Zheng X, Li H.

Adv Mater. 2019 Apr;31(17):e1807001. doi: 10.1002/adma.201807001. Epub 2019 Feb 18. Review.

PMID:
30773741

Supplemental Content

Support Center